OCT 23, 2026 · JOURNAL ARTICLE
New Horizons for Incretin-Based Therapeutics
Annual Review of Physiology
Glucagon-like peptide-1 (GLP-1)-based therapies marked a major breakthrough in obesity pharmacotherapy, while subsequent advancements targeting multiple entero-pancreatic hormones